RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
INVO Bioscience Stock

INVO Bioscience P/S 2024

INVO Bioscience P/S

0.15

Ticker

INVO

ISIN

US44984F4019

As of Nov 19, 2024, INVO Bioscience's P/S ratio stood at 0.15, a -92.96% change from the 2.13 P/S ratio recorded in the previous year.

The INVO Bioscience P/S history

INVO Bioscience Aktienanalyse

What does INVO Bioscience do?

INVO Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding INVO Bioscience's P/S Ratio

INVO Bioscience's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing INVO Bioscience's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating INVO Bioscience's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in INVO Bioscience’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about INVO Bioscience stock

What is the price-to-earnings ratio of INVO Bioscience?

The price-earnings ratio of INVO Bioscience is currently 0.15.

How has the price-earnings ratio of INVO Bioscience changed compared to last year?

The price-to-earnings ratio of INVO Bioscience has increased by -92.96% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of INVO Bioscience high compared to other companies?

Yes, the price-to-earnings ratio of INVO Bioscience is high compared to other companies.

How does an increase in the price-earnings ratio of INVO Bioscience affect the company?

An increase in the price-earnings ratio of INVO Bioscience would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of INVO Bioscience affect the company?

A decrease in the price-earnings ratio of INVO Bioscience would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of INVO Bioscience?

Some factors that influence the price-earnings ratio of INVO Bioscience are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does INVO Bioscience pay?

Over the past 12 months, INVO Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, INVO Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of INVO Bioscience?

The current dividend yield of INVO Bioscience is .

When does INVO Bioscience pay dividends?

INVO Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of INVO Bioscience?

INVO Bioscience paid dividends every year for the past 0 years.

What is the dividend of INVO Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is INVO Bioscience located?

INVO Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von INVO Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of INVO Bioscience from 11/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/19/2024.

When did INVO Bioscience pay the last dividend?

The last dividend was paid out on 11/19/2024.

What was the dividend of INVO Bioscience in the year 2023?

In the year 2023, INVO Bioscience distributed 0 USD as dividends.

In which currency does INVO Bioscience pay out the dividend?

The dividends of INVO Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von INVO Bioscience

Our stock analysis for INVO Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of INVO Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.